Literature DB >> 8831289

Cockayne syndrome--a primary defect in DNA repair, transcription, both or neither?

E C Friedberg1.   

Abstract

Cockayne syndrome is a rare autosomal recessive disease characterized by a complex clinical phenotype. Most Cockayne syndrome cells are hypersensitive to killing by ultraviolet radiation. This observation has prompted a wealth of studies on the DNA repair capacity of Cockayne syndrome cells in vitro. Many studies support the notion that such cells are defective in a DNA repair mode(s) that is transcription-dependent. However, it remains to be established that this is a primary molecular defect in Cockayne syndrome cells and that it explains the complex clinical phenotype associated with the disease. An alternative hypothesis is that Cockayne syndrome cells have a defect in transcription affecting the expression of certain genes, which is compatible with embryogenesis but not with normal post-natal development. Defective transcription may impair the normal processing of DNA damage during transcription-dependent repair.

Entities:  

Mesh:

Year:  1996        PMID: 8831289     DOI: 10.1002/bies.950180908

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  22 in total

1.  Molecular characterization of an acidic region deletion mutant of Cockayne syndrome group B protein.

Authors:  M Sunesen; R R Selzer; R M Brosh; A S Balajee; T Stevnsner; V A Bohr
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

2.  Reduced RNA polymerase II transcription in extracts of cockayne syndrome and xeroderma pigmentosum/Cockayne syndrome cells.

Authors:  G L Dianov; J F Houle; N Iyer; V A Bohr; E C Friedberg
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

3.  Differential requirement for the ATPase domain of the Cockayne syndrome group B gene in the processing of UV-induced DNA damage and 8-oxoguanine lesions in human cells.

Authors:  Rebecca R Selzer; Simon Nyaga; Jingsheng Tuo; Alfred May; Meltem Muftuoglu; Mette Christiansen; Elisabetta Citterio; Robert M Brosh; Vilhelm A Bohr
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

Review 4.  DNA Repair in Drosophila: Mutagens, Models, and Missing Genes.

Authors:  Jeff Sekelsky
Journal:  Genetics       Date:  2017-02       Impact factor: 4.562

5.  Nucleotide excision repair and photolyase preferentially repair the nontranscribed strand of RNA polymerase III-transcribed genes in Saccharomyces cerevisiae.

Authors:  A Aboussekhra; F Thoma
Journal:  Genes Dev       Date:  1998-02-01       Impact factor: 11.361

6.  Cockayne syndrome group B protein enhances elongation by RNA polymerase II.

Authors:  C P Selby; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

7.  Initiation and bidirectional propagation of chromatin assembly from a target site for nucleotide excision repair.

Authors:  Pierre-Henri L Gaillard; J G Moggs; D M Roche; J P Quivy; P B Becker; R D Wood; G Almouzni
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

8.  Identification of the XPG region that causes the onset of Cockayne syndrome by using Xpg mutant mice generated by the cDNA-mediated knock-in method.

Authors:  Naoko Shiomi; Seiji Kito; Masaki Oyama; Tsukasa Matsunaga; Yoshi-Nobu Harada; Masahito Ikawa; Masaru Okabe; Tadahiro Shiomi
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Accumulation of (5'S)-8,5'-cyclo-2'-deoxyadenosine in organs of Cockayne syndrome complementation group B gene knockout mice.

Authors:  Güldal Kirkali; Nadja C de Souza-Pinto; Pawel Jaruga; Vilhelm A Bohr; Miral Dizdaroglu
Journal:  DNA Repair (Amst)       Date:  2008-11-18

10.  Rad26p, a transcription-coupled repair factor, is recruited to the site of DNA lesion in an elongating RNA polymerase II-dependent manner in vivo.

Authors:  Shivani Malik; Priyasri Chaurasia; Shweta Lahudkar; Geetha Durairaj; Abhijit Shukla; Sukesh R Bhaumik
Journal:  Nucleic Acids Res       Date:  2009-12-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.